Lipid News

Dysregulation of a lipid transfer protein linked to brain disorders

Kentaro Hanada
By Kentaro Hanada
April 12, 2022

Advanced studies of human genetics are a big wave in the medical sciences. Collaborative teams of clinical geneticists and bioinformaticians are surfing this wave, rapidly discovering genomic variations associated with specific human disorders. This trend is providing scientific bases for personalized medicines but also new, important questions linked to the basic biochemistry field.

Ceramide transport protein, or CERT, moves the waxy lipids known as ceramides in cells for the synthesis of sphingomyelin, a membrane lipid that is ubiquitous in mammalian cells. In 2007, researchers found that CERT is functionally repressed by multiple phosphorylations of a serine-repeat motif, or SRM, in CERT. At the time, scientists regarded this finding as pure biochemistry of a protein.

However, a decade later, large-scale human genetic studies on intellectual disabilities and mental development disorders, or ID/MD, showed that missense mutations in or near the CERT SRM-encoding regions are associated with a type of autosomal dominant hereditary ID/MD. The dominant inheritance was in line with a prediction from the previous biochemical study that loss of hyperphosphorylation of the SRM renders CERT abnormally active.

Our recent collaborative study confirmed this prediction by demonstrating that substitution of a serine residue in the SRM with other residues similar to variants found in ID/MD patients results in dysregulation of CERT in cultured cells. Nonetheless, several ID/MD-associated missense mutations that occurred in the CERT gene CERT1 also are mapped outside the SRM. This riddle was answered by another recent study showing that a non-SRM variant also compromises the SRM hyperphosphorylation, thereby abnormally activating CERT.

Moreover, cell biological analysis showed that abnormally activated CERT mutants exhibit an aberrant punctate distribution in cells, suggesting that the subcellular distribution pattern is applicable as a diagnostic tool to assess whether a CERT1 variant is an abnormally activated type that may cause ID/MD, although the precise identity of the puncta structure remains undetermined.

Advanced  human genetics studies have shown that missense mutations in the CERT1 gene encoding the ceramide <em>transport protein </em>CERT are associated with certain intellectual  disabilities and mental development disorders. Recent studies in the Hanada lab  showed that ID/MD-associated CERT variants are defective in the serine-repeat  motif phosphorylation-dependent repression. In this diagram, for simplicity, CERT  is illustrated as a monomer, although it forms oligomers in cells.
Kentaro Hanada
Advanced human genetics studies have shown that missense mutations in the CERT1 gene encoding the ceramide transport protein CERT are associated with certain intellectual disabilities and mental development disorders. Recent studies in the Hanada lab showed that ID/MD-associated CERT variants are defective in the serine-repeat motif phosphorylation-dependent repression. In this diagram, for simplicity, CERT is illustrated as a monomer, although it forms oligomers in cells.

Want more lipid research news?

Check out Lipid Trends, a curated collection of hot picks from the world of lipid research, brought to you by LIPID MAPS.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Kentaro Hanada
Kentaro Hanada

Kentaro Hanada is a senior researcher in the quality assurance, radiation safety and information management department of the National Institute of Infectious Diseases in Japan, where he is also former director of the biochemistry and cell biology department and an emeritus officer.

Related articles

Acylcarnitines, a warning signal for Type 2 diabetes
Jessica W. Davidson & Judith Simcox
‘Fatty retina’: A root cause of vision loss in diabetes?
Clay Semenkovich & Rithwick Rajagopal
Targeting cardiolipin modification in a genetic disorder
Arianna F. Anzmann, Olivia Sniezek & Hilary Vernon

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Study uncovers a unique, efficient method of copper delivery in cells
News

Study uncovers a unique, efficient method of copper delivery in cells

May 28, 2023

Discovery will help in treating Menkes disease, other copper deficiency disorders.

As microbiome science forges ahead, will some be left behind?
Essay

As microbiome science forges ahead, will some be left behind?

May 27, 2023

The FDA’s approval of the first fecal microbiota treatment was a watershed moment — and also a wakeup call.

Cystic fibrosis: current understanding and prospects
Health Observance

Cystic fibrosis: current understanding and prospects

May 26, 2023

In observance of National Cystic Fibrosis Awareness Month, we talked with researcher Neil Bradbury.

A great escape — how SARS-CoV-2 evades our defenses
Journal News

A great escape — how SARS-CoV-2 evades our defenses

May 25, 2023

Preliminary evidence shows that SARS-CoV-2 uses molecular mimicry, in which one of its proteins acts like a protein in our immune system.

John H. Exton: A cell signaling pioneer
Retrospective

John H. Exton: A cell signaling pioneer

May 24, 2023

Colleagues recall a distinguished member of the Vanderbilt University faculty for six decades who had been an ASBMB member since 1970.

How 'master regulators' of cells make DNA accessible for gene expression
News

How 'master regulators' of cells make DNA accessible for gene expression

May 20, 2023

New study out of Penn State clarifies how specialized proteins open up dense complexes of genetic material for use.